Evaira 0.5 mg Injection
237,93$
185,58$
Evaira 0.5 mg Injection is a targeted anticancer therapy specifically designed for patients battling metastatic breast cancer who have undergone at least two prior chemotherapy regimens. This medication is also indicated for the treatment of unresectable liposarcoma in patients who have previously received anthracycline-based therapy for advanced or metastatic conditions, provided they are suitable candidates. By inhibiting the growth and proliferation of cancer cells, Evaira effectively works to halt the progression of these aggressive malignancies. Patients should be aware of potential side effects, including nausea and fatigue, and discuss any pre-existing health conditions with their healthcare provider before starting treatment. As with all cancer therapies, it’s crucial to follow the prescribed regimen closely and attend regular follow-up appointments to monitor treatment response. Evaira’s unique formulation offers hope for individuals facing challenging cancer diagnoses, making it an essential option in oncology. Consult your healthcare professional to see if Evaira 0.5 mg Injection is the right choice for your treatment plan.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Evaira 0.5 mg injection is primarily utilized in the treatment of metastatic breast cancer. Patients suffering from this condition may experience various symptoms, including significant pain in areas such as the bones or chest. By administering Evaira 0.5 mg injection, healthcare providers aim to alleviate these symptoms and improve the patient's overall quality of life. This targeted approach helps in managing discomfort associated with cancer spread.
• The use of Evaira 0.5 mg injection is particularly beneficial for individuals who have not responded adequately to other treatment options for metastatic breast cancer. In these cases, Evaira may help in reducing tumor growth and slowing disease progression. This can lead to improved physical functioning and a reduction in cancer-related symptoms. Patients often report a better ability to engage in daily activities following treatment with Evaira 0.5 mg injection.
• Evaira 0.5 mg injection is also indicated for patients experiencing specific symptoms such as shortness of breath or persistent cough due to metastatic breast cancer. This medication can help manage these respiratory symptoms, allowing patients to breathe more comfortably. By addressing these complications, Evaira 0.5 mg injection contributes to a more comprehensive cancer care plan. Patients may find relief from distressing symptoms that hinder their quality of life.
• In addition to managing pain and respiratory issues, Evaira 0.5 mg injection plays a role in addressing weight loss and loss of appetite associated with metastatic breast cancer. By targeting the underlying mechanisms of cancer progression, this medication can help stabilize a patient's condition. This stabilization may lead to improved nutritional status and overall well-being. Thus, Evaira 0.5 mg injection serves as an important component of supportive care for affected individuals.
Benefits
Metastatic breast cancer is a type of advanced breast cancer that has spread beyond the breast and nearby lymph nodes to other parts of the body, such as the bones, liver, lungs, or brain. Evaira 0.5 mg Injection is used when other medicines have not shown significant improvement and cancer has spread to other parts as well. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Evaira 0.5 mg kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.
Soft tissue sarcoma (Liposarcoma): soft tissue sarcoma is a group of cancers that develop in the soft tissues of the body, such as the muscles, fat, nerves, blood vessels, and connective tissues. This medicine is used who have received prior anthracycline-containing therapy and have not shown significant improvement. Evaira 0.5 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.
Side Effects
Evaira 0.5 mg Injection may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Breathlessness
• Risk of Infection
• Loss of appetite
• Headaches
• Numbness or tingling in toes and fingers
• Cough
• Feeling sick
• Diarrhoea
• Constipation
• Hair loss
• Body Pain
• Fever
• Fatigue
• Weight loss
Common Side Effects
• Sepsis
• Blood clot in veins
• Inflammation of the pancreas
• Liver Damage
• Protein and blood in your urine
• Severe skin reaction
• Bruising and bleeding
• Changes in heartbeat
How To Use
Evaira 0.5 mg is given intravenously (in vein) or as an intravenous infusion over 2 to 5 minutes by a healthcare professional, doctor or nurse in a hospital. The dosage and frequency of Evaira 0.5 mg depend on various factors, including your weight and height, your health problems and what type of cancer and condition you have. Your health professional may decrease your dose or delay your treatment if you experience serious side effects. While during the treatment closely monitor the patient while blood cell count, peripheral neuropathy signs and symptoms.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Evaira 0.5 mg Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: patients with kidney disease should closely monitor kidney function while taking Evaira 0.5 mg and report any unusual symptoms or changes in kidney function to their physician. The dose of Evaira 0.5 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Evaira 0.5 mg. Evaira 0.5 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Evaira 0.5 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Evaira 0.5 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Evaira 0.5 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Evaira 0.5 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Evaira 0.5 mg may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Evaira 0.5 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Evaira 0.5 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Evaira 0.5 mg.